Your browser doesn't support javascript.
loading
MiR-629-5p promotes the invasion of lung adenocarcinoma via increasing both tumor cell invasion and endothelial cell permeability.
Li, Yu; Zhang, Huibiao; Fan, Lei; Mou, Jiahui; Yin, Yue; Peng, Chao; Chen, Yuxiang; Lu, Henglei; Zhao, Liting; Tao, Zhouteng; Chen, Jing; Wang, Yizheng; Qi, Xinming; Huang, Ruimin; Ren, Jin.
Afiliação
  • Li Y; Center for Drug Safety Evaluation and Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 201203, Shanghai, China.
  • Zhang H; University of Chinese Academy of Sciences, 100049, Beijing, China.
  • Fan L; Department of Thoracic Surgery, Huadong Hospital, Fudan University, 200040, Shanghai, China.
  • Mou J; Center for Drug Safety Evaluation and Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 201203, Shanghai, China.
  • Yin Y; University of Chinese Academy of Sciences, 100049, Beijing, China.
  • Peng C; Center for Drug Safety Evaluation and Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 201203, Shanghai, China.
  • Chen Y; University of Chinese Academy of Sciences, 100049, Beijing, China.
  • Lu H; National Facility for Protein Science in Shanghai, Zhangjiang Lab, 201210, Shanghai, China.
  • Zhao L; Shanghai Science Research Center, Chinese Academy of Sciences, 201204, Shanghai, China.
  • Tao Z; Center for Drug Safety Evaluation and Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 201203, Shanghai, China.
  • Chen J; Center for Drug Safety Evaluation and Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 201203, Shanghai, China.
  • Wang Y; Shanghai University of Chinese Medicine, 201203, Shanghai, China.
  • Qi X; Department of Nursing, Huadong Hospital, Fudan University, 200040, Shanghai, China.
  • Huang R; Center for Drug Safety Evaluation and Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 201203, Shanghai, China.
  • Ren J; University of Chinese Academy of Sciences, 100049, Beijing, China.
Oncogene ; 39(17): 3473-3488, 2020 04.
Article em En | MEDLINE | ID: mdl-32108166

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: RNA Neoplásico / Biomarcadores Tumorais / MicroRNAs / Células Endoteliais / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: RNA Neoplásico / Biomarcadores Tumorais / MicroRNAs / Células Endoteliais / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article